- Home
- YOSH vs EYEN Comparison
YOSH vs EYEN Comparison
Compare YOSH & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOSH
- EYEN
- Stock Information
- Founded
- YOSH 2016
- EYEN 2014
- Country
- YOSH United States
- EYEN United States
- Employees
- YOSH N/A
- EYEN N/A
- Industry
- YOSH Restaurants
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- YOSH Consumer Discretionary
- EYEN Health Care
- Exchange
- YOSH Nasdaq
- EYEN Nasdaq
- Market Cap
- YOSH 5.0M
- EYEN 4.0M
- IPO Year
- YOSH 2022
- EYEN 2018
- Fundamental
- Price
- YOSH $8.76
- EYEN $1.68
- Analyst Decision
- YOSH
- EYEN Hold
- Analyst Count
- YOSH 0
- EYEN 4
- Target Price
- YOSH N/A
- EYEN $2.00
- AVG Volume (30 Days)
- YOSH 187.8K
- EYEN 267.4K
- Earning Date
- YOSH 03-31-2025
- EYEN 03-17-2025
- Dividend Yield
- YOSH N/A
- EYEN N/A
- EPS Growth
- YOSH N/A
- EYEN N/A
- EPS
- YOSH N/A
- EYEN N/A
- Revenue
- YOSH $11,652,880.00
- EYEN $31,832.00
- Revenue This Year
- YOSH N/A
- EYEN $23,413.60
- Revenue Next Year
- YOSH N/A
- EYEN $400.98
- P/E Ratio
- YOSH N/A
- EYEN N/A
- Revenue Growth
- YOSH 25.97
- EYEN 2557.10
- 52 Week Low
- YOSH $2.71
- EYEN $1.67
- 52 Week High
- YOSH $16.50
- EYEN $205.60
- Technical
- Relative Strength Index (RSI)
- YOSH 54.11
- EYEN 27.62
- Support Level
- YOSH $3.83
- EYEN $1.67
- Resistance Level
- YOSH $16.50
- EYEN $1.94
- Average True Range (ATR)
- YOSH 2.79
- EYEN 0.26
- MACD
- YOSH 0.29
- EYEN 0.22
- Stochastic Oscillator
- YOSH 41.36
- EYEN 0.80
About YOSH Yoshiharu Global Co.
Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.